CLINICAL_TRIALS
trial_result
· 2025-06-25
Clinical Trial Update: Introduction of EndoSign ® in Management of Barrett's Oesophagus - a Swedish Feasibility Study [NA]
Summary
A completed Swedish feasibility study assessing the use of EndoSign for management of Barrett Esophagus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vastra Gotaland Region | Conditions: Barrett Esophagus | NA | Status: COMPLETED